au.\*:("JAISAMRARN, U")
Results 1 to 6 of 6
Selection :
Hormonal replacement and lipid changes in post-menopausal womenLIMPAPHAYOM, K; TAECHAKRAICHANA, N; JAISAMRARN, U et al.Chot Mai Het Thang Phaet. 1996, Vol 79, Num 1, pp 10-15, issn 0125-2208Article
A comparison of cycle control, efficacy, and side effects among healthy Thai women between two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene (Meliane) and 30 μg ethinylestradiol/75 μg gestodene (Gynera®)TANEEPANICHSKUL, S; KRIENGSINYOT, R; JAISAMRARN, U et al.Contraception (Stoneham). 2002, Vol 66, Num 6, pp 407-409, issn 0010-7824, 3 p.Article
Effects of DMPA on weight and blood pressure in long term acceptorsTANEEPANICHSKUL, S; REINPRAYOON, D; JAISAMRARN, U et al.Contraception (Stoneham). 1999, Vol 59, Num 5, pp 301-303, issn 0010-7824Article
Bone loss in oophorectomized Thai womenTAECHAKRAICHANA, N; LIMPAPHAYOM, K; JAISAMRARN, U et al.Chot Mai Het Thang Phaet. 1997, Vol 80, Num 6, pp 384-390, issn 0125-2208Article
Efficacy of human papillomavirus (HPV)-16/18 ASO4-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenPAAVONEN, J; NAUD, P; HEDRICK, J et al.Lancet (British edition). 2009, Vol 374, Num 9686, pp 301-314, issn 0140-6736, 14 p.Article
Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15―25 years with and without serological evidence of previous exposure to HPV-16/18SZAREWSKI, A; POPPE, W. A. J; CASTELLSAGUE, X et al.International journal of cancer (Print). 2012, Vol 131, Num 1, pp 106-116, issn 0020-7136, 11 p.Article